Bergman, P. J., Camps-Palau, M. A., McKnight, J. A., Leibman, N. F., Craft, D. M., and et al. (2006). "Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center." Vaccine, 24(21):4582-5.
Dhama, K., Chauhan, R. S., Mahendran, M., Singhal, L. (2007). "DNA vaccines and prevention of infectious diseases in bovines: A Review." International Journal of Cow Science. 3(2):1-2.
Dhama, K., Mahendran, M., Gupta, P. K., Rai, A. (2008). "DNA vaccines and their applications in veterinary practice: current perspectives." Veterinary Research Communications. 32:341-56.
Dufour, V. (2001). "DNA vaccines: new applications for veterinary medicine." Veterinary Sciences Tomorrow. 2:1-26.
Dunham, S. P. (2002). "The application of nucleic acid vaccines in veterinary medicine." Research in Veterinary Science. 1; 73(1):9-16.
Haygreen, L., Davison, F., Kaiser, P. (2005). "DNA vaccines for poultry: the jump from theory to practice." Expert Review of Vaccines. 1; 4(1):51-62.
Khusro, A., Aarti, C., Rivas-Caceres, R. R., Barbabosa-Pliego, A. (2020). "Equine herpesvirus-I infection in horses: Recent updates on its pathogenicity, vaccination, and preventive management strategies." Journal of Equine Veterinary Science. 1; 87:102923.
Liu, M. A. (2003). "DNA vaccines: a review." Journal of Internal Medicine. 253(4):402-10.
Lopes, A., Vandermeulen, G., Préat, V. (2019). "Cancer DNA vaccines: current preclinical and clinical developments and future perspectives." Journal of Experimental & Clinical Cancer Research. 38:1-24.
Lowe, D. B., Shearer, M. H., Kennedy, R. C. (2006). "DNA vaccines: successes and limitations in cancer and infectious disease." Journal of Cellular Biochemistry. 15; 98(2):235-42.
Olsen, C. W. (2000). "DNA vaccination against influenza viruses: a review with emphasis on equine and swine influenza." Veterinary Microbiology. 22; 74(1-2):149-64.
Pasandideh, R., Seyfi Abad Shapouri, M. R., Beigi Nassiri, M. T. (2018). "Immunogenicity of a plasmid DNA vaccine encoding G1 epitope of bovine ephemeral fever virus G glycoprotein in mice." Onderstepoort Journal of Veterinary Research. 85 (1): 1617.
Pereira, V. B., Zurita-Turk, M., Saraiva, T. D., Castro, C. P., Souza, B. M., et al. (2014). "DNA vaccines approach: from concepts to applications." World Journal of Vaccines, 4, 50-71.
Reyes-Sandoval, A., Ertl, H. C. (2001). "DNA vaccines." Current Molecular Medicine. 1(2):217-43.
Saade, F., Petrovsky, N. (2012). "Technologies for enhanced efficacy of DNA vaccines." Expert Review of Vaccines. 1; 11(2):189-209.
Saiz, J. C. (2020). "Animal and human vaccines against West Nile virus." Pathogens. 21; 9(12):1073.
Schumacher, D., Tischer, B. K., Fuchs, W., Osterrieder, N. (2000). "Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant." Journal of Virology. 74(23), 11088–11098.
Sommerville, L. M., Radford, A. D., Glenn, M., Dawson, S., Gaskell, C. J., et al. (2002). "DNA vaccination against feline calicivirus infection using a plasmid encoding the mature capsid protein." Vaccine. 15; 20(13-14):1787-96.
Starodubova, E. S., Preobrazhenskaia, O. V., Kuzmenko, Y. V., Latanova, A. A., Yarygina, E. I., Karpov, V. L. (2015). "Rabies vaccines: Current status and prospects for development." Molecular Biology.49:513-9.
Van Drunen Littel‐van den Hurk, S., Babiuk, S. L., Babiuk, L. A. (2004). "Strategies for improved formulation and delivery of DNA vaccines to veterinary target species." Immunological Reviews. 199(1):113-25.
 دامِستیک', './data/domesticsj/coversheet/841722781074.jpg'))